Dietary salt exacerbates isoproterenol-induced cardiomyopathy in rats

Toxicologic Pathology

Volumn 39, Issue 6, 2011, Pages 925-937

  Carll, Alex P ^a   Haykal Coates, Najwa ^b   Winsett, Darrell W ^b   Hazari, Mehdi S ^b   Nyska, Abraham ^c   Richards, Judy H ^b   Willis, Monte S ^d   Costa, Daniel L ^b   Farraj, Aimen K ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy; salt; isoproterenol; heart failure; spontaneously hypertensive; rats; fibrosis

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6; ISOPRENALINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; CARDIOMYOPATHY; CONTROLLED STUDY; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART WEIGHT; HISTOPATHOLOGY; LUNG EDEMA; LUNG INJURY; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CARDIOMYOPATHIES; FIBROSIS; HEART; HEART FAILURE; INTERLEUKIN-6; ISOPROTERENOL; MALE; NATRIURETIC PEPTIDE, BRAIN; RATS; RATS, INBRED SHR; SODIUM CHLORIDE, DIETARY;

RATTUS;

EID: 80053610433     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311416373     Document Type: Article

References (52)

1. Ahn J., Varagic J., Slama M., Susic D., Frohlich E. D.. Cardiac structural and functional responses to salt loading in SHR. Am J Physiol Heart Circ Physiol. 2004 ; 287: H767-72
2. American Heart Association (AHA) (2010). Classification of Funcitonal Capacity and Objective Assessment. http://americanheart.org/presenter.jhtml? identifier=4569.
3. Anderson K. M., Eckhart A. D., Willette R. N., Koch W. J.. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension. 1999 ; 33: 402-7 (Pubitemid 29065692)
4. Anthony D., Montine T., Valentine W., Graham D. Casarett and Doull's Toxicology: The Basic Science of Poisons. Klaassen C., ed. New York, NY: McGraw-Hill ; 2001: 545.
5. Badenhorst D., Veliotes D., Maseko M., Tsotetsi O. J., Brooksbank R., Naidoo A., Woodiwiss A. J., Norton G. R.. Beta-adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension. 2003 ; 41: 499-504 (Pubitemid 36314623)
6. Boluyt M. O., Bing O. H., Lakatta E. G.. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur Heart J. 1995 ; 16 (Suppl N). 19-30 (Pubitemid 26082317)
7. Bos R., Mougenot N., Findji L., Mediani O., Vanhoutte P. M., Lechat P.. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. J Cardiovasc Pharmacol. 2005 ; 45: 8-13 (Pubitemid 40039749)
8. Braunwald E., Ross J., Sonnenblick E. Mechanisms of Contraction of the Normal and Failing Heart, 2nd Edition. Boston, MA: Little, Brown ; 1976: 357-397.
9. Brouri F., Hanoun N., Mediani O., Saurini F., Hamon M., Vanhoutte P. M., Lechat P.. Blockade of beta 1- and desensitization of beta 2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis. Eur J Pharmacol. 2004 ; 485: 227-34 (Pubitemid 38134419)
10. Carll A. P., Haykal-Coates N., Winsett D. W., Rowan W. H., Hazari M. S., Ledbetter A. D., Nyska A., Cascio W. E., Watkinson W. P., Costa D. L., Farraj A. K.. Particulate matter inhalation exacerbates cardiopulmonary injury in a rat model of isoproterenol-induced cardiomyopathy. Inhal Toxicol. 2010 ; 22: 355-68
11. Carll A. P., Willis M. S., Lust R. M., Costa D. L., Farraj A. K. Merits of non-invasive rat models of left ventricular heart failure. Cardiovasc Toxicol. 2011 ; 11: 91-112
12. Chagoya de Sanchez V., Hernandez-Munoz R., Lopez-Barrera F., Yanez L., Vidrio S., Suarez J., Cota-Garza M. D., Aranda-Fraustro A., Cruz D.. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Can J Physiol Pharmacol. 1997 ; 75: 1300-11 (Pubitemid 28130369)
13. Clerico A., Recchia F. A., Passino C., Emdin M.. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol. 2006 ; 290: H17-29
14. Das D. K., Engelman R. M., Kimura Y.. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res. 1993 ; 27: 578-84 (Pubitemid 23144579)
15. de Denus S., Pharand C., Williamson D. R.. Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. Chest. 2004 ; 125: 652-68 (Pubitemid 38223648)
16. de Virginy D. R.. Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure: a clinical review. Heart Fail Rev. 2006 ; 11: 333-4
17. Dhalla A. K., Hill M. F., Singal P. K.. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 1996 ; 28: 506-14 (Pubitemid 26274350)
18. Dhalla A. K., Singal P. K.. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol. 1994 ; 266: H1280-5
19. Diwan A., Dorn G. W. Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology (Bethesda). 2007 ; 22: 56-64
20. Farraj A. K., Haykal-Coates N., Ledbetter A. D., Evansky P. A., Gavett S. H.. Neurotrophin mediation of allergic airways responses to inhaled diesel particles in mice. Toxicol Sci. 2006 ; 94: 183-92 (Pubitemid 44542341)
21. Gradin K., Elam M., Persson B.. Chronic salt loading and central adrenergic mechanisms in the spontaneously hypertensive rat. Acta Pharmacol Toxicol (Copenh). 1985 ; 56: 204-13 (Pubitemid 15149186)
22. Gradin K., Nissbrand H., Ehrenstom F., Henning M., Persson B.. Adrenergic mechanisms during hypertension induced by sucrose and/or salt in the spontaneously hypertensive rat. Naunyn-Schmiedebergs Arch Pharmacol. 1988 ; 337: 47-52 (Pubitemid 18061413)
23. Gupta M., Singal P. K.. Higher antioxidative capacity during a chronic stable heart hypertrophy. Circ Res. 1989 ; 64: 398-406 (Pubitemid 19054036)
24. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G. L., Irvin C. G., Gelfand E. W.. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 1997 ; 156: 766-75 (Pubitemid 27396413)
25. Heart Failure Society of America (HFSA) (2006). Questions about HF, the stages of heart failure-NYHA classification. Accessed fromhttp://www.abouthf. org/questions-stages.htm.
26. Heyen J. R., Blasi E. R., Nikula K., Rocha R., Daust H. A., Frierdich G., Van Vleet J. F., De Ciechi P., McMahon E. G., Rudolph A. E.. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol. 2002 ; 283: H1775-84
27. Jaskot R. H., Charlet E. G., Grose E. C., Grady M. A., Roycroft J. H.. An automated analysis of glutathione peroxidase, S-transferase, and reductase activity in animal tissue. J Anal Toxicol. 1983 ; 7: 86-8 (Pubitemid 13163283)
28. Jokinen M. P., Lieuallen W. G., Johnson C. L., Dunnick J., Nyska A.. Characterization of spontaneous and chemically induced cardiac lesions in rodent model systems: the national toxicology program experience. Cardiovasc Toxicol. 2005 ; 5: 227-44 (Pubitemid 41058634)
29. Kim-Mitsuyama S., Izumi Y., Izumiya Y., Yoshida K., Yoshiyama M., Iwao H.. Additive beneficial effects of the combination of a calcium channel blocker and an angiotensin blocker on a hypertensive rat-heart failure model. Hypertens Res. 2004 ; 27: 771-9 (Pubitemid 40045517)
30. Koletsky S.. Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol. 1975 ; 80: 129-42
31. Mackenzie W. Pathology of the Fischer Rat. Boorman G., ed. San Diego, CA: Academic Press ; 1990 :
32. McCuneS.BakerP.StillsH.Jr. (1990). SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR (Institute for Laboratory Animal Research) Journal, 32. Accessed fromhttp://dels-old.nas. edu/ilar-n/ilarjournal/32-3/32-3SHHFMcccp.shtml.
33. Meszaros J., Levai G.. Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure. Acta Biol Hung. 1990 ; 41: 289-307
34. Milei J., Bolomo N. J.. A routine method for diagnosis of early myocardial infarction. Int J Cardiol. 1983 ; 4: 319-21 (Pubitemid 13006328)
35. Murray D. R., Prabhu S. D., Chandrasekar B.. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation. 2000 ; 101: 2338-41 (Pubitemid 30329120)
36. Nyska A., Mahler B., Maronpot R. Heart Trimming Protocol of the Laboratory Rat. Research Triangle Park, NC: National Institute of Environmental Health Science & National Toxicology Program ; 2005 :
37. Oliveira E. M., Krieger J. E.. Chronic beta-adrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. Eur J Pharmacol. 2005 ; 520: 135-41 (Pubitemid 41375821)
38. Rona G.. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985 ; 17: 291-306 (Pubitemid 15030720)
39. Ruben Z., Arceo R., Bishop S., Elwell M., Kerns W., Mesfin G., Sandusky G., Van Vleet J. Non-proliferative Lesions of the Heart and Vasculature in Rats. Washington, DC: U.S. Government Printing Office ; 2000 :
40. Stoupakis G., Klapholz M.. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure. Heart Dis. 2003 ; 5: 215-23 (Pubitemid 36734294)
41. Takata Y., Yamashita Y., Takishita S., Tsuchihashi T., Tomita Y., Kimura Y., Koga T., Fujishima M.. Central and peripheral mechanisms of the enhanced hypertension following long-term salt loading in spontaneously hypertensive rats. Jpn Circ J. 1988 ; 52: 1317-22
42. Takeshita D., Shimizu J., Kitagawa Y., Yamashita D., Tohne K., Nakajima-Takenaka C., Ito H., Takaki M.. Isoproterenol-induced hypertrophied rat hearts: does short-term treatment correspond to long-term treatment?. J Physiol Sci. 2008 ; 58: 179-88 (Pubitemid 351846447)
43. Tamura T., Said S., Gerdes A. M.. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension. 1999 ; 33: 676-80 (Pubitemid 29091646)
44. Thai H. M., Van H. T., Gaballa M. A., Goldman S., Raya T. E.. Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am J Physiol. 1999 ; 276: H873-80
45. Towbin J. A., Bowles N. E.. The failing heart. Nature. 2002 ; 415: 227-33 (Pubitemid 34059529)
46. Varagic J., Frohlich E. D., Diez J., Susic D., Ahn J., Gonzalez A., Lopez B.. Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol Heart Circ Physiol. 2006 ; 290: H1503-9
47. Wambach G., Koch J.. BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. Clin Exp Hypertens. 1995 ; 17: 619-29
48. Weber K. T., Brilla C. G., Campbell S. E., Zhou G., Matsubara L., Guarda E.. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure. Blood Press. 1992 ; 1: 75-85
49. Yokota N., Aburaya M., Yamamoto Y., Kato J., Kitamura K., Kida O., Eto T., Minamino N., Kangawa K., Matsuo H., et al. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration. Biochem Biophys Res Commun. 1990 ; 173: 632-8
50. Yu H. C., Burrell L. M., Black M. J., Wu L. L., Dilley R. J., Cooper M. E., Johnston C. I.. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation. 1998 ; 98: 2621-8 (Pubitemid 29001204)
51. Zhang G. X., Kimura S., Nishiyama A., Shokoji T., Rahman M., Yao L., Nagai Y., Fujisawa Y., Miyatake A., Abe Y.. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res. 2005 ; 65: 230-8 (Pubitemid 40038496)
52. Zhang W., Liu A. J., Yi-Ming W., Liu J. G., Shen F. M., Su D. F.. Pressor and non-pressor effects of sodium loading on stroke in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2008 ; 35: 83-8 (Pubitemid 350197685)